Sumitomo Dainippon Pharma Co Ltd - Net Income Including Non Controlling Interests

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Net-Income-Including-Non-Controlling-Interests" stands at 18.90 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.

Sumitomo Dainippon Pharma Co Ltd's first quarter result of 11.21 Billion JPY for the item "Net Income Including Non Controlling Interests" represents an increase of 364.02 percent compared to it's fourth quarter result of the company's last fiscal year.

Also, Sumitomo Dainippon Pharma Co Ltd's first quarter result of 11.21 Billion JPY for the item "Net Income Including Non Controlling Interests" represents a decrease of -29.68 percent compared to it's first quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's first quarter result of 18.90 Billion JPY for the item "Net Income Including Non Controlling Interests" represents a decrease of -20.01 percent compared to it's fourth quarter result of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 279.04 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 279.04 Billion Japanese Yens.
The 3 year change is -48.98 Billion Japanese Yens.
The 5 year change is -25.88 Billion Japanese Yens.
The 10 year change is 3.27 Billion Japanese Yens.

The Serie's long term average value is -6.63 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 25.54 Billion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 03/31/2024, to it's latest available value, on 06/30/2025, is +333.83 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 06/30/2022, to it's latest available value, on 06/30/2025, is -48.98 Billion.